The pooled SMD for S100B COVID-19 with and without pneumonia was 0.30 [95% CI: 0.02, 0.57], indicating that S100B levels were moderately higher in COVID-19 pneumonia patients compared to those without pneumonia. This evidence concerns the gene S100B and COVID-19.